SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-23-002471
Filing Date
2023-11-06
Accepted
2023-11-06 17:06:20
Documents
1
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form313392004_11062023.html 3  
1 OWNERSHIP DOCUMENT form313392004_11062023.xml 3 1498
  Complete submission text file 0000921895-23-002471.txt   2963
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 181 BAY STREET, SUITE 4200 TORONTO A6 M5J 2T3
Business Address
Datoo Taheer (Reporting) CIK: 0001999172 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41827 | Film No.: 231380699